This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:

BMS Reports Results from P-III (MAVA-LTE) Trial of Camzyos to Treat Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Read More: BMS                                                                                                             

Arrowhead Pharmaceuticals Reports the P-III (PALISADE) Trial Results of Plozasiran to Treat Familial Chylomicronemia Syndrome (FCS)

Read More: Arrowhead Pharmaceuticals                                                                 

Valneva and Pfizer Present P-II (VLA15-221) Study Data of VLA15 Vaccine for Lyme Disease

Read More: Valneva & Pfizer                                                                                     

Vasa Therapeutics Reports the Initiation of the P-I Trial Evaluating VS-041 for the Treatment of HFpEF

Read More: Vasa Therapeutics                                                                                

Sanofi Releases P-III (HERCULES) Data of Tolebrutinib (BTKi) for non-relapsing Secondary Progressive MS (nrSPMS)

Read More: Sanofi                                                                                                          

Roche Reports the P-II (FENopta) Study Data of Fenebrutinib for Treating Relapsing Multiple Sclerosis (RMS)

Read More: Roche                                                                                                        

Merck Commences P-IIb/III (BRUNELLO) Clinical Evaluation of Restoret to Treat Diabetic Macular Edema (DME)

Read More: Merck                                                                                                         

ALX Oncology Reports the First Patient Dosing in P-I/II (UMBRELLA) Trial of Evorpacept Plus Sarclisa for Treating R/R Multiple Myeloma (RRMM)

Read More: ALX Oncology                                                                                           

Eli Lilly Reports Topline Results from P-III (QWINT-1 and QWINT-3) Studies of Efsitora Alfa (Efsitora) for Type 2 Diabetes

Read More: Eli Lilly                                                                                                         

GSK Reports the P-III Study Results of Nucala (Mepolizumab) for Treating Chronic Obstructive Pulmonary Disease (COPD)

Read More: GSK                                                                                                              

Tempo Therapeutics Reports the First Patient Dosing in the MOSAIC Trial of TT101 for Tissue Repair in Skin Cancer Surgery

Read More: Tempo Therapeutics                                                                                

Pierre Fabre Laboratories Reports the EC’s Approval of Braftovi Plus Mektovi to Treat Advanced Non-Small Cell Lung Cancer

Read More: Pierre Fabre Laboratories                                                                    

Grit Biotechnology Reports the US FDA’s IND Approval of GT201 for Treating Advanced Solid Tumors

Read More: Grit Biotechnology                                                                                   

KalVista Reports the US FDA’s NDA Acceptance of Sebetralstat for Treating Hereditary Angioedema (HAE)

Read More: KalVista                                                                                                    

Vivet Therapeutics’ VTX-806 Receives the EC’s Orphan Drug Designation for Cerebrotendinous Xanthomatosis (CTX)

Read More: Vivet Therapeutics                                                                                   

Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma

Read More: Lisata Therapeutics                                                                                 

Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Full Approval for Treating IgA Nephropathy

Read More: Travere Therapeutics                                                                              

EDX Medical Group and Caris Life Sciences Collaborate to Distribute Molecular Profiling Across the UK & Nordic Countries

Read More: EDX Medical Group & Caris Life Sciences                                        

Jacobio and Allist Pharmaceuticals Partner to Develop Glecirasib and JAB-3312 Across China

Read More: Jacobio & Allist Pharmaceuticals                                                         

Simcere Zaiming and TargetRx Team Up to Develop TGRX-326 for Non-Small Cell Lung Cancer

Read More: Simcere Zaiming & TargetRx                                                                 

Acepodia Partners with Pfizer to Develop Antibody-Cell Conjugation-Based Cell Therapies for Autoimmune Disorders

Read More: Acepodia & Pfizer                                                                                   

EpimAb Biotherapeutics and Vignette Bio Partner to Develop EMB-06 for Autoimmune Disorders

Read More: EpimAb & Vignette Bio                                                                          

Novavax’s 2024-2025 Formula COVID-19 Vaccine Receives Emergency Use Authorization in the US

Read More: Novavax                                                                                                      

Elixir Medical Highlights the Data from INFINITY-SWEDEHEART Study of DynamX Coronary Bioadaptor System for Coronary Artery Disease at ESC 2024

Read More: Elixir Medical                                                                            

Abbott Reports the Initiation of TRANSCEND Trial Assessing Deep Brain Stimulation System to Manage Severe Depression (TRD)

Read More: Abbott                                                                                                    

Turing Medical’s Bullsai Identify Platform Receives the US FDA’s Clearance for Precision Brain Mapping

Read More: Turing Medical                                                                                

Boehringer Ingelheim Reports the Acquisition of Saiba Animal Health, Strengthening its R&D Portfolio Focusing on Animal Health

Read More: Boehringer Ingelheim & Saiba Animal Health                                 

Digital Health

Viz.ai Collaborates with Addario Lung Cancer Medical Institute (ALCMI) to Integrate AI into Lung Cancer Detection

Read More: Viz.ai & Addario Lung Cancer                                                                   

HAYA Therapeutics and Eli Lilly Partner to Discover Novel Regulatory Genome Targets for Obesity and Other Metabolic Conditions

Read More: HAYA Therapeutics & Eli Lilly                                                              

Related Post: PharmaShots Weekly Snapshots (August 26 – August 30, 2024)